Dopamine Infusion
Syringe pump continuous infusion preparation (4,000 mcg/mL), dose-dependent hemodynamic titration, and extravasation surveillance protocol.
Syringe Pump Infusion Preparation (Standard Concentration)
| Ampoule Presentation | 5 mL ampoule (40 mg/mL of dopamine hydrochloride) |
|---|---|
| Dopamine Dose | 200 mg (5 mL = one 5 mL ampoule) |
| Compatible Diluent | 45 mL of D5W or 0.9% Sodium Chloride (NS) |
| Final Syringe Volume | 50 mL |
| Final Concentration | 4,000 mcg/mL (4 mg/mL) |
| Stability | 24 hours at room temperature |
Materials Required
- Dopamine ampoule 40 mg/mL (5 mL) × 1
- 60 mL Luer-lock syringe
- 0.9% Sodium Chloride (NS) or 5% Dextrose (D5W)
- Sterile drawing-up needle / filter needle
- Dedicated syringe pump infusion label
- Extension line (100 cm)
- Alcohol chlorhexidine swabs
Preparation Procedure (Aseptic Non-Touch Technique)
- Verification: Verify the written physician order, patient identity, body weight, and clinical indication.
- Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
- Ampoule Check: Check the dopamine ampoule for:
- Correct drug and strength, dopamine hydrochloride (40 mg/mL)
- Expiry date
- Container integrity, clarity, and absence of precipitate or discoloration
- Withdrawal: Open one ampoule of dopamine. Withdraw 5 mL into a 60 mL Luer-lock syringe (Total dopamine drawn: 5 mL = 200 mg dopamine).
- Dilution: Add 45 mL of 0.9% Sodium Chloride or D5W to a final volume of 50 mL.
- Mixing: Gently invert the syringe several times to ensure uniform mixing.
- Visual Inspection: Inspect solution to ensure it is clear, colorless, and free of visible particles. A pink, yellow, or brown tint indicates drug decomposition; discard the syringe.
- Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
- Syringe Pump Setup: Prime the extension set, install into the syringe pump, and shield from excessive ambient light.
🔒 Lumen Policy: Dopamine is inactivated in alkaline solutions (sodium bicarbonate, aminophylline, furosemide) and is incompatible with numerous medications. It must be infused via a dedicated central venous catheter lumen whenever possible.
⚠️ Peripheral Administration: In an emergency situation, dopamine may be infused peripherally through a large proximal vein for short-term bridging use only, with frequent site monitoring for extravasation.
Dose-Dependent Receptor Effects
Dopamine's hemodynamic effect changes with dose. Thresholds overlap and vary considerably between patients, so titrate to clinical response rather than to a fixed tier.
Low Dose (Dopaminergic)
- D1 receptor stimulation: renal and splanchnic vasodilation
- "Renal-dose" dopamine is not recommended; it does not prevent or treat acute kidney injury
Intermediate Dose (Inotropic)
- β1 stimulation: increased contractility, heart rate, and cardiac output
- Useful for symptomatic bradycardia unresponsive to atropine
High Dose (Vasopressor)
- α1 stimulation: systemic vasoconstriction, raised SVR and blood pressure
- Marked rise in tachyarrhythmia risk and myocardial oxygen demand
Administration & Titration
Recommended Dosing Parameters
- Administration Route: Administer via syringe pump; dedicated central line lumen preferred.
- Recommended Starting Dose: 2 to 5 mcg/kg/min (titrate infusion to achieve desired hemodynamic result).
- Titration Step: Increase by 1 to 4 mcg/kg/min every 10 to 30 minutes according to response.
- Symptomatic Bradycardia: 5 to 20 mcg/kg/min, titrated to heart rate and blood pressure response.
- Maximum Dose: 20 mcg/kg/min. If further support is needed, add or switch to an alternative vasopressor under intensivist supervision.
- Hypovolemia: Correct intravascular volume depletion before or during initiation.
- Weaning: Taper gradually; abrupt discontinuation may cause marked hypotension.
- Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
- Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.
Hemodynamic Monitoring Requirements
- Monitor arterial blood pressure continuously (invasive arterial line preferred).
- Monitor heart rate and continuous ECG rhythm for sinus tachycardia, atrial fibrillation, and ventricular ectopy.
- Observe for chest pain or ECG changes suggesting myocardial ischemia.
- Monitor for peripheral tissue ischemia or necrosis, particularly at high doses.
- Assess end-organ perfusion markers (urine output, mental status, peripheral pulse volume, serum lactate).
Clinical Cautions
- Septic Shock: Noradrenaline is the preferred first-line vasopressor; dopamine is associated with more arrhythmias.
- MAO Inhibitors: Effects markedly prolonged and intensified; a substantially reduced starting dose is required.
- Contraindicated: Pheochromocytoma and uncorrected tachyarrhythmias or ventricular fibrillation.
Extravasation Surveillance & Response Protocol
Extravasation of dopamine causes severe local vasoconstriction leading to ischemic sloughing and necrosis.
Normal Infusion Site
- No cutaneous blanching
- No local swelling
- No pain, burning, or stinging
- No tissue discolouration
Extravasation Suspected:
- STOP infusion immediately (do not flush line).
- Notify clinician promptly.
- Aspirate residual drug through the cannula if possible, then remove catheter.
- Document event in patient clinical record.
Dopamine Infusion Rate Chart (4,000 mcg/mL)
Shows equivalent dose in mcg/kg/min for a given pump rate (mL/hr) across patient weights. Central venous line administration preferred.
| Rate (mL/hr) |
Weight (Kg) and Dose (mcg/kg/min) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 kg | 45 kg | 50 kg | 55 kg | 60 kg | 65 kg | 70 kg | 75 kg | 80 kg | 85 kg | 90 kg | 95 kg | 100 kg | |
| 1 | 1.7 | 1.5 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 |
| 2 | 3.3 | 3.0 | 2.7 | 2.4 | 2.2 | 2.1 | 1.9 | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.3 |
| 3 | 5.0 | 4.4 | 4.0 | 3.6 | 3.3 | 3.1 | 2.9 | 2.7 | 2.5 | 2.4 | 2.2 | 2.1 | 2.0 |
| 4 | 6.7 | 5.9 | 5.3 | 4.8 | 4.4 | 4.1 | 3.8 | 3.6 | 3.3 | 3.1 | 3.0 | 2.8 | 2.7 |
| 5 | 8.3 | 7.4 | 6.7 | 6.1 | 5.6 | 5.1 | 4.8 | 4.4 | 4.2 | 3.9 | 3.7 | 3.5 | 3.3 |
| 6 | 10.0 | 8.9 | 8.0 | 7.3 | 6.7 | 6.2 | 5.7 | 5.3 | 5.0 | 4.7 | 4.4 | 4.2 | 4.0 |
| 7 | 11.7 | 10.4 | 9.3 | 8.5 | 7.8 | 7.2 | 6.7 | 6.2 | 5.8 | 5.5 | 5.2 | 4.9 | 4.7 |
| 8 | 13.3 | 11.9 | 10.7 | 9.7 | 8.9 | 8.2 | 7.6 | 7.1 | 6.7 | 6.3 | 5.9 | 5.6 | 5.3 |
| 9 | 15.0 | 13.3 | 12.0 | 10.9 | 10.0 | 9.2 | 8.6 | 8.0 | 7.5 | 7.1 | 6.7 | 6.3 | 6.0 |
| 10 | 16.7 | 14.8 | 13.3 | 12.1 | 11.1 | 10.3 | 9.5 | 8.9 | 8.3 | 7.8 | 7.4 | 7.0 | 6.7 |
| 11 | 18.3 | 16.3 | 14.7 | 13.3 | 12.2 | 11.3 | 10.5 | 9.8 | 9.2 | 8.6 | 8.1 | 7.7 | 7.3 |
| 12 | 20.0 | 17.8 | 16.0 | 14.5 | 13.3 | 12.3 | 11.4 | 10.7 | 10.0 | 9.4 | 8.9 | 8.4 | 8.0 |
| 13 | 21.7 | 19.3 | 17.3 | 15.8 | 14.4 | 13.3 | 12.4 | 11.6 | 10.8 | 10.2 | 9.6 | 9.1 | 8.7 |
| 14 | 23.3 | 20.7 | 18.7 | 17.0 | 15.6 | 14.4 | 13.3 | 12.4 | 11.7 | 11.0 | 10.4 | 9.8 | 9.3 |
| 15 | 25.0 | 22.2 | 20.0 | 18.2 | 16.7 | 15.4 | 14.3 | 13.3 | 12.5 | 11.8 | 11.1 | 10.5 | 10.0 |
| 16 | 26.7 | 23.7 | 21.3 | 19.4 | 17.8 | 16.4 | 15.2 | 14.2 | 13.3 | 12.5 | 11.9 | 11.2 | 10.7 |
| 17 | 28.3 | 25.2 | 22.7 | 20.6 | 18.9 | 17.4 | 16.2 | 15.1 | 14.2 | 13.3 | 12.6 | 11.9 | 11.3 |
| 18 | 30.0 | 26.7 | 24.0 | 21.8 | 20.0 | 18.5 | 17.1 | 16.0 | 15.0 | 14.1 | 13.3 | 12.6 | 12.0 |
| 19 | 31.7 | 28.1 | 25.3 | 23.0 | 21.1 | 19.5 | 18.1 | 16.9 | 15.8 | 14.9 | 14.1 | 13.3 | 12.7 |
| 20 | 33.3 | 29.6 | 26.7 | 24.2 | 22.2 | 20.5 | 19.0 | 17.8 | 16.7 | 15.7 | 14.8 | 14.0 | 13.3 |
| 21 | 35.0 | 31.1 | 28.0 | 25.5 | 23.3 | 21.5 | 20.0 | 18.7 | 17.5 | 16.5 | 15.6 | 14.7 | 14.0 |
| 22 | 36.7 | 32.6 | 29.3 | 26.7 | 24.4 | 22.6 | 21.0 | 19.6 | 18.3 | 17.3 | 16.3 | 15.4 | 14.7 |
| 23 | 38.3 | 34.1 | 30.7 | 27.9 | 25.6 | 23.6 | 21.9 | 20.4 | 19.2 | 18.0 | 17.0 | 16.1 | 15.3 |
| 24 | 40.0 | 35.6 | 32.0 | 29.1 | 26.7 | 24.6 | 22.9 | 21.3 | 20.0 | 18.8 | 17.8 | 16.8 | 16.0 |
| 25 | 41.7 | 37.0 | 33.3 | 30.3 | 27.8 | 25.6 | 23.8 | 22.2 | 20.8 | 19.6 | 18.5 | 17.5 | 16.7 |
| 26 | 43.3 | 38.5 | 34.7 | 31.5 | 28.9 | 26.7 | 24.8 | 23.1 | 21.7 | 20.4 | 19.3 | 18.2 | 17.3 |
| 27 | 45.0 | 40.0 | 36.0 | 32.7 | 30.0 | 27.7 | 25.7 | 24.0 | 22.5 | 21.2 | 20.0 | 18.9 | 18.0 |
| 28 | 46.7 | 41.5 | 37.3 | 33.9 | 31.1 | 28.7 | 26.7 | 24.9 | 23.3 | 22.0 | 20.7 | 19.6 | 18.7 |
| 29 | 48.3 | 43.0 | 38.7 | 35.2 | 32.2 | 29.7 | 27.6 | 25.8 | 24.2 | 22.7 | 21.5 | 20.4 | 19.3 |
| 30 | 50.0 | 44.4 | 40.0 | 36.4 | 33.3 | 30.8 | 28.6 | 26.7 | 25.0 | 23.5 | 22.2 | 21.1 | 20.0 |
Infusion Conversion (Solution Concentration 4,000 mcg/mL)
Standard equations for a 4,000 mcg/mL solution (200 mg in 50 mL):
Rate (mL/hr) = [ Dose (mcg/kg/min) × Weight (kg) × 60 ] / 4000
Shortcut: Rate = Dose × Weight × 0.015
Dose (mcg/kg/min) = [ Rate (mL/hour) × Concentration (4000 mcg/mL) ] / [ Weight (kg) × 60 ]
'Shortcut' example: 70 kg patient at 5 mcg/kg/min → 5 × 70 × 0.015 = 5.25 mL/hr.